CRO support for ncats drug product development, manufacture, and stability studies

Ended Awarded Last action

Contract number
HHSN271201700019I
Awardee
Awarding agency
Task orders
2 $1,081,559 obligated

Award facts

Opportunity
Combined order value
$1,081,559 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 7% used
$14,444,775.00
Award type
Multiple award
Who can order
Only the awarding agency
Funding agency
National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
Set-aside
No set-aside
Competition
Full and Open Competition · 4 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)

Award details come from SAM.gov/FPDS.

About this IDV

The University of Iowa was awarded a multiple-award indefinite delivery contract by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to provide contract research organization (CRO) support for drug product development, manufacturing, and stability studies. The contract has a ceiling value of $14,444,775 and a period of performance through July 2024.

Under this IDIQ contract, the University of Iowa has received two delivery orders to date. The first, valued at $470,254, is for dosage form development, manufacture, and stability studies of GS-441524 in support of the National Institute on Drug Abuse's research efforts. The second, valued at $611,305, is for dosage form development, manufacture, and stability studies of parathyroid hormone for injection, supporting NCATS' mission to advance new medical treatments. These task orders do not carry set-aside designations, and the work is performed at the University's facilities in Iowa City, Iowa. The University of Iowa has a strong track record of providing research, healthcare, and specialized services to various federal agencies, leveraging its academic and scientific expertise to support government initiatives.

Task orders

Transactions

Action Obligated Date
Other Administrative Action P00008 $0
Other Administrative Action P00007 $0
Supplemental Agreement for work within scope P00006 $0
Funding Only Action P00005 -$5,000
Supplemental Agreement for work within scope P00004 $0
Other Administrative Action P00003 $0
Other Administrative Action 2 $0
Other Administrative Action 1 $0
Original award $5,000

Quick answers

Who was awarded contract HHSN271201700019I?

HHSN271201700019I was awarded to The University Of Iowa by National Institute on Drug Abuse (National Institutes of Health) on August 1, 2017.

How much is contract HHSN271201700019I worth?

Orders under HHSN271201700019I have obligated $1,081,559. HHSN271201700019I's own ceiling is $14,444,775.

How many orders have been placed under contract HHSN271201700019I?

2 orders have been placed under HHSN271201700019I, the latest on May 10, 2021.

Which agency awarded contract HHSN271201700019I?

National Institute on Drug Abuse (National Institutes of Health) awarded HHSN271201700019I, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).

Who can order from contract HHSN271201700019I?

HHSN271201700019I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract HHSN271201700019I part of a contract vehicle?

Yes. HHSN271201700019I is part of NCATS Drug Product Development Studies 2017-2022.

Was contract HHSN271201700019I competed?

The extent of competition for HHSN271201700019I was full and open competition. The government received 4 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV